Can changing the prodrug moiety in remdesivir be a life-saving strategy in COVID-19 infection?

Saved in:
Bibliographic Details
Published in:Indian journal of medical research (New Delhi, India : 1994) India : 1994), 2023-01, Vol.157 (1), p.100-103
Main Authors: Prabha, Praisy, Prakash, Ajay, Medhi, Bikash
Format: Article
Language:English
Subjects:
Antiviral drugs
Control
Epidemics
India
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites cdi_FETCH-LOGICAL-c367g-4290116899a0192f9d12d01ad882cabcf1cd59de0c8f684bbbf13b32fa5007613
container_end_page 103
container_issue 1
container_start_page 100
container_title Indian journal of medical research (New Delhi, India : 1994)
container_volume 157
creator Prabha, Praisy
Prakash, Ajay
Medhi, Bikash
description
doi_str_mv 10.4103/ijmr.ijmr_233_22
format article
fullrecord <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_2799827822</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A748337209</galeid><sourcerecordid>A748337209</sourcerecordid><originalsourceid>FETCH-LOGICAL-c367g-4290116899a0192f9d12d01ad882cabcf1cd59de0c8f684bbbf13b32fa5007613</originalsourceid><addsrcrecordid>eNp1kc1vFCEYxjlobF29ezIkXrzMysfODJxMs7XapEkv6lHCwMuU7QxUmOmm_71Mt_UrGhIg8HuePG8ehF5Rst5Qwt_53ZjWy6YY54qxJ-iYyJZWtaTNEXqe844QKlkrn6Ej3rQ1bev6GH3b6oDNlQ69Dz2ergDfpGjT3OMxepjusA84wWgh-1ufcAdY48E7qLK-XRR5SnqC_p7bXn49P62oLHcHZvIxvH-Bnjo9ZHj5cK7Ql7MPn7efqovLj-fbk4vKlCh9tWGSUNoIKfWS0UlLmSVUWyGY0Z1x1NhaWiBGuEZsuq5zlHecOV0T0jaUr9Dbg29J_32GPKnRZwPDoAPEOasythSsFYwV9M1f6C7OKZR0igkiOWuIrH9RvR5AlYFiGdQspuqk3QjOW1bYFVr_gyrLwuhNDOB8ef9DQA4Ck2LOCZy6SX7U6U5RopYa1X2Dv9VYJK8f8s7dCPan4LHDApwdgH0cJkj5epj3kFRhr0Pc_9e4fBBV2leP7fMfjrGy_Q</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2809326095</pqid></control><display><type>article</type><title>Can changing the prodrug moiety in remdesivir be a life-saving strategy in COVID-19 infection?</title><source>Publicly Available Content Database</source><source>PubMed Central</source><source>Coronavirus Research Database</source><creator>Prabha, Praisy ; Prakash, Ajay ; Medhi, Bikash</creator><creatorcontrib>Prabha, Praisy ; Prakash, Ajay ; Medhi, Bikash</creatorcontrib><identifier>ISSN: 0971-5916</identifier><identifier>DOI: 10.4103/ijmr.ijmr_233_22</identifier><identifier>PMID: 36751755</identifier><language>eng</language><publisher>India: Wolters Kluwer India Pvt. Ltd</publisher><subject>Antiviral drugs ; Control ; Epidemics ; India</subject><ispartof>Indian journal of medical research (New Delhi, India : 1994), 2023-01, Vol.157 (1), p.100-103</ispartof><rights>COPYRIGHT 2023 Medknow Publications and Media Pvt. Ltd.</rights><rights>2023. This article is published under (http://creativecommons.org/licenses/by-nc-sa/3.0/) (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c367g-4290116899a0192f9d12d01ad882cabcf1cd59de0c8f684bbbf13b32fa5007613</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.proquest.com/docview/2809326095?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>314,778,782,25740,27911,27912,36999,37000,38503,43882,44577</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/36751755$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Prabha, Praisy</creatorcontrib><creatorcontrib>Prakash, Ajay</creatorcontrib><creatorcontrib>Medhi, Bikash</creatorcontrib><title>Can changing the prodrug moiety in remdesivir be a life-saving strategy in COVID-19 infection?</title><title>Indian journal of medical research (New Delhi, India : 1994)</title><addtitle>Indian J Med Res</addtitle><subject>Antiviral drugs</subject><subject>Control</subject><subject>Epidemics</subject><subject>India</subject><issn>0971-5916</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>COVID</sourceid><sourceid>PIMPY</sourceid><recordid>eNp1kc1vFCEYxjlobF29ezIkXrzMysfODJxMs7XapEkv6lHCwMuU7QxUmOmm_71Mt_UrGhIg8HuePG8ehF5Rst5Qwt_53ZjWy6YY54qxJ-iYyJZWtaTNEXqe844QKlkrn6Ej3rQ1bev6GH3b6oDNlQ69Dz2ergDfpGjT3OMxepjusA84wWgh-1ufcAdY48E7qLK-XRR5SnqC_p7bXn49P62oLHcHZvIxvH-Bnjo9ZHj5cK7Ql7MPn7efqovLj-fbk4vKlCh9tWGSUNoIKfWS0UlLmSVUWyGY0Z1x1NhaWiBGuEZsuq5zlHecOV0T0jaUr9Dbg29J_32GPKnRZwPDoAPEOasythSsFYwV9M1f6C7OKZR0igkiOWuIrH9RvR5AlYFiGdQspuqk3QjOW1bYFVr_gyrLwuhNDOB8ef9DQA4Ck2LOCZy6SX7U6U5RopYa1X2Dv9VYJK8f8s7dCPan4LHDApwdgH0cJkj5epj3kFRhr0Pc_9e4fBBV2leP7fMfjrGy_Q</recordid><startdate>20230101</startdate><enddate>20230101</enddate><creator>Prabha, Praisy</creator><creator>Prakash, Ajay</creator><creator>Medhi, Bikash</creator><general>Wolters Kluwer India Pvt. Ltd</general><general>Medknow Publications and Media Pvt. Ltd</general><general>Scientific Scholar</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88I</scope><scope>8AF</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>COVID</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>M2P</scope><scope>MBDVC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>S0X</scope><scope>7X8</scope></search><sort><creationdate>20230101</creationdate><title>Can changing the prodrug moiety in remdesivir be a life-saving strategy in COVID-19 infection?</title><author>Prabha, Praisy ; Prakash, Ajay ; Medhi, Bikash</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c367g-4290116899a0192f9d12d01ad882cabcf1cd59de0c8f684bbbf13b32fa5007613</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Antiviral drugs</topic><topic>Control</topic><topic>Epidemics</topic><topic>India</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Prabha, Praisy</creatorcontrib><creatorcontrib>Prakash, Ajay</creatorcontrib><creatorcontrib>Medhi, Bikash</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>STEM Database</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Coronavirus Research Database</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest research library</collection><collection>Science Database</collection><collection>Research Library (Corporate)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>SIRS Editorial</collection><collection>MEDLINE - Academic</collection><jtitle>Indian journal of medical research (New Delhi, India : 1994)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Prabha, Praisy</au><au>Prakash, Ajay</au><au>Medhi, Bikash</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Can changing the prodrug moiety in remdesivir be a life-saving strategy in COVID-19 infection?</atitle><jtitle>Indian journal of medical research (New Delhi, India : 1994)</jtitle><addtitle>Indian J Med Res</addtitle><date>2023-01-01</date><risdate>2023</risdate><volume>157</volume><issue>1</issue><spage>100</spage><epage>103</epage><pages>100-103</pages><issn>0971-5916</issn><cop>India</cop><pub>Wolters Kluwer India Pvt. Ltd</pub><pmid>36751755</pmid><doi>10.4103/ijmr.ijmr_233_22</doi><tpages>4</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0971-5916
ispartof Indian journal of medical research (New Delhi, India : 1994), 2023-01, Vol.157 (1), p.100-103
issn 0971-5916
language eng
recordid cdi_proquest_miscellaneous_2799827822
source Publicly Available Content Database; PubMed Central; Coronavirus Research Database
subjects Antiviral drugs
Control
Epidemics
India
title Can changing the prodrug moiety in remdesivir be a life-saving strategy in COVID-19 infection?
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-15T16%3A00%3A11IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Can%20changing%20the%20prodrug%20moiety%20in%20remdesivir%20be%20a%20life-saving%20strategy%20in%20COVID-19%20infection?&rft.jtitle=Indian%20journal%20of%20medical%20research%20(New%20Delhi,%20India%20:%201994)&rft.au=Prabha,%20Praisy&rft.date=2023-01-01&rft.volume=157&rft.issue=1&rft.spage=100&rft.epage=103&rft.pages=100-103&rft.issn=0971-5916&rft_id=info:doi/10.4103/ijmr.ijmr_233_22&rft_dat=%3Cgale_proqu%3EA748337209%3C/gale_proqu%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c367g-4290116899a0192f9d12d01ad882cabcf1cd59de0c8f684bbbf13b32fa5007613%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2809326095&rft_id=info:pmid/36751755&rft_galeid=A748337209&rfr_iscdi=true